BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23044645)

  • 1. Smoking and survival after radical cystectomy for bladder cancer.
    Lee C; Kim KH; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    Urology; 2012 Dec; 80(6):1307-12. PubMed ID: 23044645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
    Boström PJ; Alkhateeb S; Trottier G; Athanasopoulos PZ; Mirtti T; Kortekangas H; Laato M; van Rhijn B; van der Kwast T; Fleshner NE; Jewett MA; Finelli A; Zlotta AR
    BJU Int; 2012 Jan; 109(1):70-6. PubMed ID: 21851540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
    Serretta V; Altieri V; Morgia G; Di Lallo A; Carrieri G; Allegro R;
    Urology; 2013 Feb; 81(2):277-81. PubMed ID: 23374781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
    Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S
    BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.
    Lammers RJ; Witjes WP; Hendricksen K; Caris CT; Janzing-Pastors MH; Witjes JA
    Eur Urol; 2011 Oct; 60(4):713-20. PubMed ID: 21794974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
    Segal R; Yafi FA; Brimo F; Tanguay S; Aprikian A; Kassouf W
    BJU Int; 2012 Apr; 109(7):1026-30. PubMed ID: 21883838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
    Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
    Takayanagi A; Masumori N; Takahashi A; Takagi Y; Tsukamoto T
    Int J Urol; 2012 Mar; 19(3):229-33. PubMed ID: 22121922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.
    Bassi P; Ferrante GD; Piazza N; Spinadin R; Carando R; Pappagallo G; Pagano F
    J Urol; 1999 May; 161(5):1494-7. PubMed ID: 10210380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy.
    Resorlu B; Baltaci S; Resorlu M; Ergun G; Abdulmajeed M; Haliloglu AH; Gogus C; Beduk Y
    Urol Int; 2009; 83(3):285-8. PubMed ID: 19829026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.